Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | FORLENZA, Orestes Vicente | |
dc.contributor.author | DINIZ, Breno Satler | |
dc.contributor.author | TEIXEIRA, Antonio Lucio | |
dc.contributor.author | RADANOVIC, Marcia | |
dc.contributor.author | TALIB, Leda Leme | |
dc.contributor.author | ROCHA, Natalia Pessoa | |
dc.contributor.author | GATTAZ, Wagner Farid | |
dc.date.accessioned | 2015-10-26T16:31:59Z | |
dc.date.available | 2015-10-26T16:31:59Z | |
dc.date.issued | 2015 | |
dc.description.abstract | There is little information on the dynamics of BDNF in the CSF in the continuum between healthy aging, MCI and AD. We included 128 older adults (77 with amnestic MCI, 26 with AD and 25 healthy controls). CSF BDNF level was measured by ELISA assay, and AD biomarkers (A beta(42), T-Tau and P-Tau(181)) were measured using a Luminex xMAP assay. CSF BDNF levels were significantly reduced in AD subjects compared to MCI and healthy controls (p = 0.009). Logistic regression models showed that lower CSF BDNF levels (p = 0.008), lower CSF A beta(42) (p = 0.005) and lower MMSE scores (p = 0.007) are significantly associated with progression from MCI to AD. The present study adds strong evidence of the involvement of BDNF in the pathophysiology of neurodegenerative changes in AD. Interventions aiming to restore central neurotrophic support may represent future therapeutic targets to prevent or delay the progression from MCI to AD. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472138/2013-8, 466623/2014-3] | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [02/12633-7] | |
dc.description.sponsorship | Associacao Beneficente Alzira Denise Hertzog da Silva (ABADHS) | |
dc.identifier.citation | NEUROMOLECULAR MEDICINE, v.17, n.3, p.326-332, 2015 | |
dc.identifier.doi | 10.1007/s12017-015-8361-y | |
dc.identifier.eissn | 1559-1174 | |
dc.identifier.issn | 1535-1084 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/11789 | |
dc.language.iso | eng | |
dc.publisher | HUMANA PRESS INC | |
dc.relation.ispartof | Neuromolecular Medicine | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright HUMANA PRESS INC | |
dc.subject | Alzheimer's disease | |
dc.subject | Mild cognitive impairment | |
dc.subject | Brain-derived neurotrophic factor | |
dc.subject | Cerebrospinal fluid | |
dc.subject | Biomarkers | |
dc.subject | Pathophysiology | |
dc.subject.other | late-life depression | |
dc.subject.other | major depression | |
dc.subject.other | serum bdnf | |
dc.subject.other | val66met polymorphism | |
dc.subject.other | controlled-trial | |
dc.subject.other | markers | |
dc.subject.other | csf | |
dc.subject.wos | Neurosciences | |
dc.title | Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.author.external | DINIZ, Breno Satler:Univ Sao Paulo, Fac Med, Dept & Inst Psychiat, Lab Neurosci LIM 27, BR-05403010 Sao Paulo, SP, Brazil; Univ Fed Minas Gerais, Fac Med, Dept Mental Hlth, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Fac Med, Natl Inst Sci & Technol Mol Med INCT MM, Belo Horizonte, MG, Brazil | |
hcfmusp.author.external | TEIXEIRA, Antonio Lucio:Univ Fed Minas Gerais, Fac Med, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil | |
hcfmusp.author.external | ROCHA, Natalia Pessoa:Univ Fed Minas Gerais, Fac Med, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil | |
hcfmusp.citation.scopus | 55 | |
hcfmusp.contributor.author-fmusphc | ORESTES VICENTE FORLENZA | |
hcfmusp.contributor.author-fmusphc | MARCIA RADANOVIC | |
hcfmusp.contributor.author-fmusphc | LEDA LEME TALIB | |
hcfmusp.contributor.author-fmusphc | WAGNER FARID GATTAZ | |
hcfmusp.description.beginpage | 326 | |
hcfmusp.description.endpage | 332 | |
hcfmusp.description.issue | 3 | |
hcfmusp.description.volume | 17 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 26138246 | |
hcfmusp.origem.scopus | 2-s2.0-84938971568 | |
hcfmusp.origem.wos | WOS:000359552200009 | |
hcfmusp.publisher.city | TOTOWA | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x | |
hcfmusp.relation.reference | Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15 | |
hcfmusp.relation.reference | Blasko I, 2006, DEMENT GERIATR COGN, V21, P9, DOI 10.1159/000089137 | |
hcfmusp.relation.reference | Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309 | |
hcfmusp.relation.reference | Christensen R, 2008, EXP NEUROL, V210, P164, DOI 10.1016/j.expneurol.2007.10.009 | |
hcfmusp.relation.reference | Clement F, 2010, BIOL PSYCHIAT, V68, P894, DOI 10.1016/j.biopsych.2010.02.004 | |
hcfmusp.relation.reference | Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158 | |
hcfmusp.relation.reference | de Sousa RT, 2011, NEUROSCI LETT, V494, P54, DOI 10.1016/j.neulet.2011.02.054 | |
hcfmusp.relation.reference | Diniz BS, 2010, WORLD J BIOL PSYCHIA, V11, P550, DOI 10.3109/15622970903544620 | |
hcfmusp.relation.reference | Diniz BS, 2011, NEUROMOL MED, V13, P217, DOI 10.1007/s12017-011-8154-x | |
hcfmusp.relation.reference | Diniz BS, 2014, J GERONTOL B-PSYCHOL, V69, P845, DOI 10.1093/geronb/gbu096 | |
hcfmusp.relation.reference | Diniz BS, 2015, MOL PSYCHIATR, V20, P594, DOI 10.1038/mp.2014.76 | |
hcfmusp.relation.reference | Diniz BS, 2014, J PSYCHIATR RES, V49, P96, DOI 10.1016/j.jpsychires.2013.11.004 | |
hcfmusp.relation.reference | Douillard-Guilloux G, 2013, AM J GERIAT PSYCHIAT, V21, P450, DOI 10.1016/j.jagp.2013.01.040 | |
hcfmusp.relation.reference | Faria MC, 2014, J PSYCHIATR RES, V53, P166, DOI 10.1016/j.jpsychires.2014.01.019 | |
hcfmusp.relation.reference | Forlenza OV, 2010, WORLD J BIOL PSYCHIA, V11, P774, DOI 10.3109/15622971003797241 | |
hcfmusp.relation.reference | Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044 | |
hcfmusp.relation.reference | Forlenza OV, 2010, REV BRAS PSIQUIATR, V32, P216, DOI 10.1590/S1516-44462010005000002 | |
hcfmusp.relation.reference | Huijbers W, 2015, BRAIN, V138, P1023, DOI 10.1093/brain/awv007 | |
hcfmusp.relation.reference | Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014 | |
hcfmusp.relation.reference | Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424 | |
hcfmusp.relation.reference | MCKHANN G, 1984, NEUROLOGY, V34, P939 | |
hcfmusp.relation.reference | Miller SL, 2008, J NEUROL NEUROSUR PS, V79, P630, DOI 10.1136/jnnp.2007.124149 | |
hcfmusp.relation.reference | Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912 | |
hcfmusp.relation.reference | Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x | |
hcfmusp.relation.reference | Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985 | |
hcfmusp.relation.reference | PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3 | |
hcfmusp.relation.reference | Rockenstein E, 2011, J NEUROSCI RES, V89, P1812, DOI 10.1002/jnr.22712 | |
hcfmusp.relation.reference | Shimada H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00069 | |
hcfmusp.relation.reference | Sibille Etienne, 2013, Dialogues Clin Neurosci, V15, P53 | |
hcfmusp.relation.reference | Teixeira AL, 2010, BIOMARK MED, V4, P871, DOI [10.2217/bmm.10.111, 10.2217/BMM.10.111] | |
hcfmusp.relation.reference | Weinstein G, 2014, JAMA NEUROL, V71, P55, DOI 10.1001/jamaneurol.2013.4781 | |
hcfmusp.relation.reference | Yu H, 2008, J CLIN PSYCHIAT, V69, P1104 | |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | 5d22f916-9e62-48bf-99aa-65b7cb87cb46 | |
relation.isAuthorOfPublication | 7991507e-d193-44b4-9c29-cd25f0228a4b | |
relation.isAuthorOfPublication | 65a65251-2a2e-454e-991f-07d85966f440 | |
relation.isAuthorOfPublication | 125dcc9f-a05a-42fd-ab1d-b6db35d2616b | |
relation.isAuthorOfPublication.latestForDiscovery | 5d22f916-9e62-48bf-99aa-65b7cb87cb46 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_FORLENZA_Lower_Cerebrospinal_Fluid_Concentration_of_BrainDerived_Neurotrophic_Factor_2015.PDF
- Tamanho:
- 371.72 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)